Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1996-04-16
1997-11-25
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
568368, A61K 3112
Patent
active
056913869
ABSTRACT:
A novel hypoglycemically active triterpenoid compound isolated in purified, preferably substantially purified, form from Salacia spp., processes for obtaining the novel triterpenoid compound, compositions comprising the triterpenoid compound and methods for use a hypoglycemic agent, for example, in the treatment of diabetes, are described. In a preferred embodiment, the triterpenoid compound is obtained from Salacia prinoides. As an agent for the treatment of diabetes, the novel triterpenoid is useful for treating insulin-dependent (type I) and/or non-insulin-dependent (type II) diabetes.
REFERENCES:
Bouboutou et al, Chem. Abst.; vol. 119, #271,442u (1993).
Pradham et al, Indian J. of Chem., vol. 32B, pp. 920-923 (1993).
Burkhill et al., A Dictionary of the Economic Products of the Malay Peninsula, (Ministry of Agriculture and Co-operative, Kuala, Lumpur, Malaysia) vol. II, pp. 1976-1977 (1966).
Heymann et al., "Characterization of Two Substances Isolated from an Indian Shrub", JACS 76(4):3689-3693 (1954).
John, "One Hundred Useful Raw Drugs of the Kani Tribes of Trivandrum Forest Division, Kerala, India", Int. J. Crude Drug Res. 22(1):17-39 (1984).
Joshi et al., "Triterpenes of Salacia prinoides DC", Tetrahedron 29:1365-1374 (1973).
Karunanayake et al., "Mangiferin from the Root Bark of Salacia reticulata", J. Ethnophamacology 13:227-228 (1985).
Krishnan et al., "Proanthocyaniding of Salacia chinensis Linn.", Tetrahedron Letters 26:2441-2446 (1967).
Mehra et al., "Pharmocognosy of Saptrangi--Antidiabetic Drug of Indian Origin", Research bulletin (N.S.) of the Panjab University 20(III-IV):487-502 (1969).
Quisumbing, Medicinal Plants of the Phillippines, (Republic of the Phillipines Department of Agriculture and Natural Resources), Technical Bulletin, 16, p.546 (1951).
Serasinghe et al., "Oral Hypoglycemic Effect of Salacia reticula in the Streptozoticin Induced Diabetic Rat", Pytotherapy Research, 4(5):205-206 (1990).
Venkateswarlu et al., "Pharmaceutical Investigations of a Film Forming Material Isolated From Roots of Salacia macrosperma", Drug Development and Industrial Pharmacy 19(4):461-472 (1993).
Inman Wayne D.
Reed Michael John
Reamer James H.
Shaman Pharmaceuticals, Inc.
LandOfFree
Triterpenoid compound for the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triterpenoid compound for the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triterpenoid compound for the treatment of diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107558